CLARITIN (LORATIDINE) COULD ADD $200-$300 MIL. IN SALES TO SCHERING's WORLDWIDE DRUG BUSINESS ONCE ESTABLISHED, PRESIDENT KOGAN TELLS ANALYSTS: LAUNCH IN EARLY 1988

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet